Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $474.30 | Total: $2,371.50 |
| 1 | 10 | $401.76 | Total: $4,017.60 |
| 1 | 25 | $340.38 | Total: $8,509.50 |
| 1 | 50 | $290.16 | Total: $14,508.00 |
| 1 | 100 | $251.10 | Total: $25,110.01 |
Overview
PI3K?mTOR-IN-1 is a potent dual inhibitor of PI3K?mTOR, with an IC50 of 7 nM for PI3K? in a cell assay and Kis of 12.5 nM and 10.6 nM for mTOR and PI3K? [in a cell-free assay], respectively.
Chemical Properties
| Molecular Formula | C16H18N6O |
| Molecular Weight | 310.35 |
| CAS Numbers | 1013098-90-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C1N(C=2C(C=C1C=3C=NNC3)=C(C)N=C(N)N2)C4CCCC4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Le PT, et al. Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3K? and mTOR. Bioorg Med Chem Lett. 2012 Aug 1;22[15] 5098-103.